Brittany Weed
Physician Assistant · Layton, UTNPI 1538779996
Payments from drug & device makers
Across 84 payments — averaging $21.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$349
- AbbVie$204
- Lilly USA, LLC$132
- GSK$122
- Seagen Inc.$118
- Johnson & Johnson$90
- plus $761 from 19 others
What the payments were for
- Food & beverage$1,58689%
- Education$19011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 18 | $349 |
| AbbVie | 6 | $204 |
| Lilly USA, LLC | 7 | $132 |
| GSK | 6 | $122 |
| Seagen Inc. | 2 | $118 |
| Johnson & Johnson | 1 | $90 |
| Pfizer | 8 | $84 |
| AstraZeneca | 4 | $81 |
| Collegium Pharmaceutical, Inc. | 5 | $77 |
| Sanofi | 3 | $67 |
| Novartis | 3 | $56 |
| Tempus AI, Inc | 2 | $51 |
| Array Biopharma Inc | 3 | $46 |
| Stemline Therapeutics Inc. | 1 | $41 |
| Biodelivery Sciences International, Inc. | 3 | $35 |
| Amgen | 2 | $35 |
| Genmab U.S., Inc. | 2 | $34 |
| Bayer | 1 | $30 |
| Bristol Myers Squibb | 1 | $28 |
| ADC Therapeutics America, Inc. | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Foundation Medicine, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $14 |
| Virtus Pharmaceuticals LLC | 1 | $12 |
| Redhill Biopharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Venclexta$122
How this compares
$1,776 in reported general payments places this provider in the 80th percentile of 1,543 physician assistant providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IbrancePalbociclib | 13 | $206,612 |
| Tamoxifen Citrate | 27 | $935 |
| Anastrozole | 41 | $586 |
| Acyclovir | 21 | $288 |
| Tramadol Hcl | 18 | $146 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $139 |
| Alendronate Sodium | 15 | $57 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerIbrance | $84 | $206,61213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,543 physician assistant providers in Utah.
Other physician assistant in Layton
- Brady TuckerLayton$14K
- Mandi ChristensenLayton$6K
- Regan BrooksSlc$606K
- Keri HolyoakMidvale$438K
- Jill EricksonSalt Lake City$179K
- Vanessa Beard-ElyMurray$80K
- Natalie BeeSalt Lake City$63K
- Jasmin CharlesTaylorsville$46K
- Luke JenkinsWest Jordan$46K
- Chanise FrandsenSandy$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.